ImageProVision proudly participated in BioAsia 2026, held on 17–18 February 2026 at HITEX Exhibition Centre, Hyderabad. As one of Asia’s premier life sciences and biotechnology events, BioAsia brought together global leaders, innovators, pharmaceutical companies, and technology providers to explore the future of healthcare, automation, and biological sciences.
At Booth No. 41, Hall 4, ImageProVision showcased its flagship CLAIRITY™ Suite, an advanced AI-powered inspection and analysis platform designed specifically for pharmaceutical and life sciences applications. The event provided an excellent opportunity to demonstrate how CLAIRITY™ is transforming quality control processes through intelligent automation, high-precision imaging, and advanced analytical capabilities.
Visitors experienced live demonstrations of multiple CLAIRITY™ modules, highlighting key capabilities such as:
API particle characterization
Foreign matter detection and inspection
Deformulation and material analysis
Hot stage microscopy for thermal characterization
Automated microbial colony counting
AI-powered proofreading and visual inspection
These demonstrations enabled attendees to witness firsthand how CLAIRITY™ enhances efficiency, accuracy, and reliability in pharmaceutical quality control workflows.
The CLAIRITY™ Suite is designed to support global regulatory and pharmacopeial requirements, including:
21 CFR Part 11 compliance
USP <695>, <776>, <788>, <789>, <790>, and <1776>
EU GMP Annex 11
Subvisible particle analysis as per USP <1788.2> and EP 2.9.19-2
This ensures pharmaceutical manufacturers can confidently adopt CLAIRITY™ to meet stringent quality and compliance standards.
BioAsia 2026 provided an excellent platform to connect with pharmaceutical manufacturers, quality control leaders, researchers, and industry partners. The response to CLAIRITY™ was overwhelmingly positive, with attendees recognizing its potential to streamline inspection processes, reduce manual effort, and improve analytical accuracy.
Our team engaged in insightful discussions with industry professionals, gaining valuable perspectives on current challenges and emerging needs in pharmaceutical quality control and analytical workflows.
ImageProVision remains committed to advancing innovation in pharmaceutical inspection and analysis. Our participation in BioAsia 2026 reinforces our mission to empower laboratories and manufacturers with intelligent, automated solutions that enhance productivity and ensure regulatory compliance.
We thank all visitors, partners, and industry professionals who visited our booth and contributed to making BioAsia 2026 a successful and meaningful event.
To learn more about the CLAIRITY™ Suite,
https://www.imageprovision.com/products/clairity-suite/
